Sponsor or institution
Clinical trials and research at National Institute of Cardiovascular Diseases, Pakistan
As of November 12, 2026, Find a Trial lists 7 clinical trials run by National Institute of Cardiovascular Diseases, Pakistan that are recruiting, in Pakistan. By phase: Phase 3 (3), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Ivabradine for cardiogenic shock after a heart attack | Phase 3 | Karachi | Recruiting | Jul 20, 2026 |
| Adenosine given before primary PCI to reduce no-reflow in STEMI patients. | Phase 4 | Karachi, Sindh and 1 other locations | Recruiting | Apr 17, 2026 |
| Drug-coated balloon versus drug-eluting stent for young adults with STEMI | Phase 3 | Karachi | Recruiting | Nov 14, 2025 |
| Using Apixaban to prevent blood clots after heart attacks | Phase 3 | Karachi, Sindh | Recruiting | Dec 19, 2024 |
| Registry of patients in preventive cardiology clinics | — | Karachi, Sindh | Recruiting | Jul 16, 2024 |
| Registry for echocardiographic screening in pregnant women | — | Karachi, Sindh | Recruiting | Aug 22, 2023 |
| Screening for Rheumatic Heart Disease in Rural Communities | — | Karachi, Sindh | Recruiting | Aug 14, 2023 |
All recruiting trials (7)
-
Ivabradine for cardiogenic shock after a heart attack
A study tests whether taking ivabradine can help people with cardiogenic shock after a heart attack move down at least one class on the SCAI scale and need less time on blood pressure or heart-support medicines.
-
Adenosine given before primary PCI to reduce no-reflow in STEMI patients.
See if giving intracoronary adenosine before primary PCI lowers the chance of slow flow/no-reflow in adults with STEMI.
-
Drug-coated balloon versus drug-eluting stent for young adults with STEMI
This study tests whether a paclitaxel-coated balloon works as well as a drug-eluting stent for adults under 50 who have a STEMI and undergo primary PCI.
-
Using Apixaban to prevent blood clots after heart attacks
This study is testing if a low dose of Apixaban can help prevent blood clots in people who have had a heart attack and have weak heart function.
-
Registry of patients in preventive cardiology clinics
This study is creating a registry of patients visiting preventive cardiology clinics to see how well we can identify heart health risks and work together on treatment plans.
-
Registry for echocardiographic screening in pregnant women
This study is testing how echocardiograms can help check the heart health of pregnant women during their routine doctor visits to catch any problems early.
-
Screening for Rheumatic Heart Disease in Rural Communities
This study is testing if using ultrasound to screen for Rheumatic Heart Disease in rural communities can help find and treat the condition early to improve health outcomes.
Quick answers
How many clinical trials run by National Institute of Cardiovascular Diseases, Pakistan are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Pakistan. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.